IPN, New Delhi can facilitate patient to import of "Speciality Products" for personal use under "patient name basis" treatment in India. For this applicant is required to make an request application with required document. IPN, New Delhi will do the necessary process to obtain permission from Drugs Controller General (India) to import.
Your blood is living tissue made up of liquid and solids. The liquid part, called plasma, is made of water, salts and protein. Over half of your blood is plasma. The solid part of your blood contains red blood cells, white blood cells and platelets.
Diabetes affect one or more parts of the blood and prevent your blood from doing its job. They can be acute or chronic. Many Diabetes are inherited. Other causes include other diseases, side effects of medicines, and a lack of certain nutrients in your diet.
Types of Diabetes include
1. Platelet disorders, excessive clotting, and bleeding problems, which affect how your blood clots
2. Anemia, which happens when your blood does not carry enough oxygen to the rest of your body
3. Cancers of the blood, such as leukemia and myeloma
4. Eosinophilic disorders, which are problems with one type of white blood cell.
The following lists anti-cancer drugs, US FDA and Indian Generic brand approved by the Food and Drug Administration (FDA) for Diabetes treatment. The list includes generic and brand names are in some way related to, or used in the treatment of this condition. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
OZEMPIC (semaglutide) injection, for subcutaneous use Initial U.S. Approval: 2017More Details...
KOMBIGLYZE XR (saxagliptin and metformin HCl extended-release) tablets Initial U.S. Approval: 2010More Details...
TRULICITY (dulaglutide) injection, for subcutaneous use Initial U.S. Approval: 2014More Details...
BYDUREON (exenatide extended-release) for injectable suspension, for subcutaneous use Initial U.S. Approval: 2005More Details...
SAXENDA (liraglutide injection), solution for subcutaneous use Initial U.S. Approval: 2014 (Saxenda, Victoza)More Details...
We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.
Indian Pharma Network is registered medical pharmacy for Oncology Products in India.Helps you to access FDA approved Diabetes medicines, no matter where you live. Sourcing each medicine for named patient use and overseeing every aspect of the shipping, customs and delivery. We have helped more than 6,000 patients. Send your enquiry to find the What is the cost of Diabetes Medicines in China, UAE, Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.
If you have a question relating to anti-cancer medicines approved for treatment of Diabetes, a problem which you do not know how to resolve it, or concrete inquiry - we are here for you. We will answer you via email email@example.com as soon as possible. If you prefer to be contacted by phone, please leave your phone number. Or text your message in WhatsApp Number +91 9891296838 / 9811747774.